Alzheimer's Risk Score Calculator (G340075)

Target Name: ARSI

NCBI ID: G340075

ARSI

Alzheimer's Risk Score Calculator

ARSI (Alzheimer's Risk Score) is a mathematical formula that is used to assess the risk of developing Alzheimer's disease. It is calculated by taking into account a number of factors, including age, gender, and a person's overall health. The higher the score, the greater the risk of developing Alzheimer's disease.

ARSI is calculated by taking into account a number of factors, including age, gender, and a person's overall health.

The score is based on a number of different factors, including age, gender, and a person's overall health. It is calculated by taking these factors into account and assigning a score that ranges from 0 to 120. The higher the score, the greater the risk of developing Alzheimer's disease.

One of the factors that is used to calculate the score is a person's age. For example, a person who is 75 years old will have a score of 75, while a person who is 85 years old will have a score of 85. This is because as a person gets older, their risk of developing Alzheimer's disease increases.

Another factor that is used to calculate the score is a person's gender. For example, women tend to have a higher risk of developing Alzheimer's disease than men. This is because women are more likely to have the genetic predisposition for the disease.

Additionally, a person's overall health is also taken into account when calculating the score. For example, a person who has a heart attack or other serious health condition is more likely to have a higher risk of developing Alzheimer's disease.

It is important to note that the score is just one tool that can be used to assess the risk of developing Alzheimer's disease. It is not a definitive predictor, and a person can still develop the disease even if their score is low. However, a higher score does increase the risk of developing the disease significantly.

The score is calculated by taking into account a number of different factors, including age, gender, and a person's overall health. It is based on these factors and assigns a score that ranges from 0 to 120. The higher the score, the greater the risk of developing Alzheimer's disease.

It is important to note that the score is just one tool that can be used to assess the risk of developing Alzheimer's disease. It is not a definitive predictor, and a person can still develop the disease even if their score is low. However, a higher score does increase the risk of developing the disease significantly.

If you are concerned about your risk of developing Alzheimer's disease, it is a good idea to talk to your doctor. They can assess your risk and help you develop a plan to reduce your risk. Additionally, maintaining a healthy lifestyle, including a diet rich in fruits and vegetables and a regular exercise program, may also help reduce your risk of developing Alzheimer's disease.

Protein Name: Arylsulfatase Family Member I

Functions: Displays arylsulfatase activity at neutral pH, when co-expressed with SUMF1; arylsulfatase activity is measured in the secretion medium of retinal cell line, but no activity is recorded when measured in cell extracts (PubMed:19262745). Lacks arylsulfatase activity (PubMed:16500042)

The "ARSI Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARSI comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets